Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. 1998

V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
Institut de Chimie Pharmaceutique, Lille, France.

A previous paper reported the synthesis of melatonin receptor ligands. In order to complete the structure-activity relationships and to obtain antagonists to the melatonin receptor, a new series of naphthalenic analogues of melatonin have been synthesized. Modifications include deletion of the 7-methoxy group, replacement of the ethylene moiety, replacement of the amidic function by bioisosteres, and replacement of the naphthalenic nucleus by other bicyclic rings. Almost all the structural modifications lead to decreased affinity for the melatonin receptor. However, the N-n propyl urea derivative (27) is a very potent ligand at this receptor (pKi = 14.3). Most interestingly deletion of the methoxy group resulted in the first antagonist in this series. This molecule, compound 12, or N-[2-(1-naphthyl)-ethyl]cyclobutyl carboxamide has been selected for preclinical development.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D005260 Female Females
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D044094 Receptors, Melatonin A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES. Melatonin Receptors,MT3 Receptor,Mel(1c) Receptor,Melatonin MT3 Receptor,Receptor, Mel1c,Receptor, Melatonin,Receptor, Melatonin, 1C,Receptor, Melatonin, MT3,MT3 Receptor, Melatonin,Mel1c Receptor,Melatonin Receptor,Receptor, MT3,Receptor, Melatonin MT3
D018160 Receptors, Cytoplasmic and Nuclear Intracellular receptors that can be found in the cytoplasm or in the nucleus. They bind to extracellular signaling molecules that migrate through or are transported across the CELL MEMBRANE. Many members of this class of receptors occur in the cytoplasm and are transported to the CELL NUCLEUS upon ligand-binding where they signal via DNA-binding and transcription regulation. Also included in this category are receptors found on INTRACELLULAR MEMBRANES that act via mechanisms similar to CELL SURFACE RECEPTORS. Cytoplasmic Receptor,Cytoplasmic and Nuclear Receptors,Cytosolic and Nuclear Receptors,Hormone Receptors, Cytoplasmic,Hormone Receptors, Nuclear,Nuclear Hormone Receptor,Nuclear Receptor,Nuclear and Cytoplasmic Receptors,Cytoplasmic Hormone Receptors,Cytoplasmic Receptors,Cytosol and Nuclear Receptors,Intracellular Membrane Receptors,Nuclear Hormone Receptors,Nuclear Receptors,Receptors, Cytoplasmic,Receptors, Cytosol and Nuclear,Receptors, Cytosolic and Nuclear,Receptors, Intracellular Membrane,Receptors, Nuclear,Receptors, Nuclear and Cytoplasmic,Hormone Receptor, Nuclear,Membrane Receptors, Intracellular,Receptor, Cytoplasmic,Receptor, Nuclear,Receptor, Nuclear Hormone,Receptors, Cytoplasmic Hormone,Receptors, Nuclear Hormone

Related Publications

V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
September 1994, Journal of medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
June 2002, Journal of medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
May 2011, European journal of medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
April 1992, Journal of medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
October 2015, Chemical biology & drug design,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
July 2004, Bioorganic & medicinal chemistry letters,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
January 2004, Bioorganic & medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
January 2013, Bioorganic & medicinal chemistry,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
November 2014, Archiv der Pharmazie,
V Leclerc, and E Fourmaintraux, and P Depreux, and D Lesieur, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola-Lemaître, and J Andrieux
November 2002, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!